Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors
[Display omitted] Cardiovascular complications are included among the systemic effects of tyrosine kinase inhibitor (TKI)-based therapeutic strategies. To test the hypothesis that inhibition of Kit tyrosine kinase that promotes cardiac progenitor cell (CPC) survival and function may be one of the tr...
Saved in:
| Published in | Pharmacological research Vol. 127; pp. 15 - 25 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier Ltd
01.01.2018
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1043-6618 1096-1186 1096-1186 |
| DOI | 10.1016/j.phrs.2017.09.020 |
Cover
| Abstract | [Display omitted]
Cardiovascular complications are included among the systemic effects of tyrosine kinase inhibitor (TKI)-based therapeutic strategies. To test the hypothesis that inhibition of Kit tyrosine kinase that promotes cardiac progenitor cell (CPC) survival and function may be one of the triggering mechanisms of imatinib mesylate (IM)-related cardiovascular effects, the anatomical, structural and ultrastructural changes in the heart of IM-treated rats were evaluated. Cardiac anatomy in IM-exposed rats showed a dose-dependent, restrictive type of remodeling and depressed hemodynamic performance in the absence of remarkable myocardial fibrosis. The effects of IM on rat and human CPCs were also assessed. IM induced rat CPC depletion, reduced growth and increased cell death. Similar effects were observed in CPCs isolated from human hearts. These results extend the notion that cardiovascular side effects are driven by multiple actions of IM. The identification of cellular mechanisms responsible for cardiovascular complications due to TKIs will enable future strategies aimed at preserving concomitantly cardiac integrity and anti-tumor activity of advanced cancer treatment. |
|---|---|
| AbstractList | Cardiovascular complications are included among the systemic effects of tyrosine kinase inhibitor (TKI)-based therapeutic strategies. To test the hypothesis that inhibition of Kit tyrosine kinase that promotes cardiac progenitor cell (CPC) survival and function may be one of the triggering mechanisms of imatinib mesylate (IM)-related cardiovascular effects, the anatomical, structural and ultrastructural changes in the heart of IM-treated rats were evaluated. Cardiac anatomy in IM-exposed rats showed a dose-dependent, restrictive type of remodeling and depressed hemodynamic performance in the absence of remarkable myocardial fibrosis. The effects of IM on rat and human CPCs were also assessed. IM induced rat CPC depletion, reduced growth and increased cell death. Similar effects were observed in CPCs isolated from human hearts. These results extend the notion that cardiovascular side effects are driven by multiple actions of IM. The identification of cellular mechanisms responsible for cardiovascular complications due to TKIs will enable future strategies aimed at preserving concomitantly cardiac integrity and anti-tumor activity of advanced cancer treatment.Cardiovascular complications are included among the systemic effects of tyrosine kinase inhibitor (TKI)-based therapeutic strategies. To test the hypothesis that inhibition of Kit tyrosine kinase that promotes cardiac progenitor cell (CPC) survival and function may be one of the triggering mechanisms of imatinib mesylate (IM)-related cardiovascular effects, the anatomical, structural and ultrastructural changes in the heart of IM-treated rats were evaluated. Cardiac anatomy in IM-exposed rats showed a dose-dependent, restrictive type of remodeling and depressed hemodynamic performance in the absence of remarkable myocardial fibrosis. The effects of IM on rat and human CPCs were also assessed. IM induced rat CPC depletion, reduced growth and increased cell death. Similar effects were observed in CPCs isolated from human hearts. These results extend the notion that cardiovascular side effects are driven by multiple actions of IM. The identification of cellular mechanisms responsible for cardiovascular complications due to TKIs will enable future strategies aimed at preserving concomitantly cardiac integrity and anti-tumor activity of advanced cancer treatment. Cardiovascular complications are included among the systemic effects of tyrosine kinase inhibitor (TKI)-based therapeutic strategies. To test the hypothesis that inhibition of Kit tyrosine kinase that promotes cardiac progenitor cell (CPC) survival and function may be one of the triggering mechanisms of imatinib mesylate (IM)-related cardiovascular effects, the anatomical, structural and ultrastructural changes in the heart of IM-treated rats were evaluated. Cardiac anatomy in IM-exposed rats showed a dose-dependent, restrictive type of remodeling and depressed hemodynamic performance in the absence of remarkable myocardial fibrosis. The effects of IM on rat and human CPCs were also assessed. IM induced rat CPC depletion, reduced growth and increased cell death. Similar effects were observed in CPCs isolated from human hearts. These results extend the notion that cardiovascular side effects are driven by multiple actions of IM. The identification of cellular mechanisms responsible for cardiovascular complications due to TKIs will enable future strategies aimed at preserving concomitantly cardiac integrity and anti-tumor activity of advanced cancer treatment. [Display omitted] Cardiovascular complications are included among the systemic effects of tyrosine kinase inhibitor (TKI)-based therapeutic strategies. To test the hypothesis that inhibition of Kit tyrosine kinase that promotes cardiac progenitor cell (CPC) survival and function may be one of the triggering mechanisms of imatinib mesylate (IM)-related cardiovascular effects, the anatomical, structural and ultrastructural changes in the heart of IM-treated rats were evaluated. Cardiac anatomy in IM-exposed rats showed a dose-dependent, restrictive type of remodeling and depressed hemodynamic performance in the absence of remarkable myocardial fibrosis. The effects of IM on rat and human CPCs were also assessed. IM induced rat CPC depletion, reduced growth and increased cell death. Similar effects were observed in CPCs isolated from human hearts. These results extend the notion that cardiovascular side effects are driven by multiple actions of IM. The identification of cellular mechanisms responsible for cardiovascular complications due to TKIs will enable future strategies aimed at preserving concomitantly cardiac integrity and anti-tumor activity of advanced cancer treatment. |
| Author | Prezioso, Lucia Urbanek, Konrad Madeddu, Denise Corradini, Emilia Berrino, Liberato De Angelis, Antonella Falco, Angela Quaini, Federico Cappetta, Donato Galati, Serena Mazzaschi, Giulia Cavalli, Stefano Lagrasta, Costanza Anna Maria Savi, Monia Frati, Caterina Buschini, Annamaria Aversa, Franco Graiani, Gallia Galaverna, Federica |
| Author_xml | – sequence: 1 givenname: Monia surname: Savi fullname: Savi, Monia organization: Department of Medicine and Surgery, University of Parma, Parma, Italy – sequence: 2 givenname: Caterina surname: Frati fullname: Frati, Caterina organization: Department of Medicine and Surgery, University of Parma, Parma, Italy – sequence: 3 givenname: Stefano surname: Cavalli fullname: Cavalli, Stefano organization: Department of Medicine and Surgery, University of Parma, Parma, Italy – sequence: 4 givenname: Gallia surname: Graiani fullname: Graiani, Gallia organization: Department of Medicine and Surgery, University of Parma, Parma, Italy – sequence: 5 givenname: Serena surname: Galati fullname: Galati, Serena organization: Department of Medicine and Surgery, University of Parma, Parma, Italy – sequence: 6 givenname: Annamaria surname: Buschini fullname: Buschini, Annamaria organization: Department of Genetics, Biology of Microorganisms, Anthropology, Evolution, University of Parma, Parma, Italy – sequence: 7 givenname: Denise surname: Madeddu fullname: Madeddu, Denise organization: Department of Medicine and Surgery, University of Parma, Parma, Italy – sequence: 8 givenname: Angela surname: Falco fullname: Falco, Angela organization: Department of Medicine and Surgery, University of Parma, Parma, Italy – sequence: 9 givenname: Lucia surname: Prezioso fullname: Prezioso, Lucia organization: Department of Medicine and Surgery, University of Parma, Parma, Italy – sequence: 10 givenname: Giulia surname: Mazzaschi fullname: Mazzaschi, Giulia organization: Department of Medicine and Surgery, University of Parma, Parma, Italy – sequence: 11 givenname: Federica surname: Galaverna fullname: Galaverna, Federica organization: Department of Medicine and Surgery, University of Parma, Parma, Italy – sequence: 12 givenname: Costanza Anna Maria surname: Lagrasta fullname: Lagrasta, Costanza Anna Maria organization: Department of Medicine and Surgery, University of Parma, Parma, Italy – sequence: 13 givenname: Emilia surname: Corradini fullname: Corradini, Emilia organization: Department of Medicine and Surgery, University of Parma, Parma, Italy – sequence: 14 givenname: Antonella surname: De Angelis fullname: De Angelis, Antonella organization: Department of Experimental Medicine, Section of Pharmacology, University of Campania “Luigi Vanvitelli”, Naples, Italy – sequence: 15 givenname: Donato surname: Cappetta fullname: Cappetta, Donato organization: Department of Experimental Medicine, Section of Pharmacology, University of Campania “Luigi Vanvitelli”, Naples, Italy – sequence: 16 givenname: Liberato surname: Berrino fullname: Berrino, Liberato organization: Department of Experimental Medicine, Section of Pharmacology, University of Campania “Luigi Vanvitelli”, Naples, Italy – sequence: 17 givenname: Franco surname: Aversa fullname: Aversa, Franco organization: Department of Medicine and Surgery, University of Parma, Parma, Italy – sequence: 18 givenname: Federico surname: Quaini fullname: Quaini, Federico email: federico.quaini@unipr.it organization: Department of Medicine and Surgery, University of Parma, Parma, Italy – sequence: 19 givenname: Konrad surname: Urbanek fullname: Urbanek, Konrad email: konrad.urbanek@unicampania.it organization: Department of Experimental Medicine, Section of Pharmacology, University of Campania “Luigi Vanvitelli”, Naples, Italy |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28964914$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kD1PwzAQQC0EAlr4AwwoI0vC2XEdW2JBiC8JwQKz5ThXcJXYxXYr9d-TqmVhYLob3ruT3oQc-uCRkAsKFQUqrhfV8iumigFtKlAVMDggpxSUKCmV4nC787oUgsoTMklpAQCKUzgmJ0wqwRXlp-T1eTDZedcWA6ZNbzKWzncri11hTexcGDZhafLXpnB-Hfo1piJich36vAOMLZYxfKJ3OcR0Ro7mpk94vp9T8vFw_373VL68PT7f3b6UljOWyxpqxWSLYlajAkMlWJRGyVpyUO3cmq4TDZOCAUjBRauUbBuG3Fo-o9JAPSVXu7vj7-8VpqwHlyz2vfEYVklTxWcNbQTlI3q5R1ftgJ1eRjeYuNG_DUZA7gAbQ0oR59q6PEYJPkfjek1Bb3Prhd7m1tvcGpQec48q-6P-Xv9XutlJOAZaO4w6WYd-TO4i2qy74P7TfwDh4Jls |
| CitedBy_id | crossref_primary_10_1093_cvr_cvz214 crossref_primary_10_3390_ijms231911812 crossref_primary_10_1016_j_phrs_2018_04_020 crossref_primary_10_1016_j_biopha_2019_108883 crossref_primary_10_3389_fcvm_2021_624028 crossref_primary_10_1038_s41598_024_57097_9 crossref_primary_10_1007_s00432_023_05459_7 crossref_primary_10_1038_s41598_022_13203_3 crossref_primary_10_1016_j_ahj_2020_05_008 crossref_primary_10_31083_j_rcm2503074 crossref_primary_10_1016_j_toxrep_2021_05_008 crossref_primary_10_1039_D2FO03331C crossref_primary_10_1016_j_phrs_2017_12_014 |
| Cites_doi | 10.1016/j.phrs.2017.06.007 10.1007/s00395-013-0334-4 10.1016/j.ejca.2017.03.024 10.3324/haematol.2013.095372 10.1161/CIRCRESAHA.116.303595 10.1038/nprot.2014.113 10.1166/jbt.2017.1543 10.1038/leu.2016.154 10.1016/j.ijcard.2017.02.154 10.1038/nrd3252 10.1200/JCO.2006.09.1611 10.18632/oncotarget.11468 10.1016/S0140-6736(12)60195-0 10.1038/nm1446 10.1161/CIRCRESAHA.111.263830 10.1161/CIRCHEARTFAILURE.114.001711 10.1016/j.ijcard.2017.02.106 10.3389/fcvm.2017.00047 10.1016/j.bbamcr.2012.08.023 10.1016/j.phrs.2017.03.016 10.1073/pnas.0909207107 10.1016/j.scr.2014.04.008 10.2174/187152510790796165 10.1038/sj.leu.2404397 10.1089/scd.2012.0542 10.1161/CIRCULATIONAHA.109.895771 10.1111/j.1582-4934.2011.01393.x 10.1182/blood-2002-04-1246 10.1016/j.jacc.2017.06.012 10.1161/CIRCRESAHA.116.309281 10.1152/ajpheart.00035.2015 10.1016/j.phrs.2017.03.011 10.1186/s40959-016-0012-4 10.1016/S0140-6736(11)61590-0 10.1161/CIRCULATIONAHA.107.708107 10.1038/nrc2106 10.1371/journal.pone.0140798 10.1161/CIRCULATIONAHA.109.902221 10.1016/j.ijcard.2015.03.438 10.1016/j.phrs.2017.05.023 10.1056/NEJMp1313140 10.1056/NEJMoa020150 10.1016/j.phrs.2017.05.024 10.1056/NEJMsa060185 10.1016/j.phrs.2017.02.015 |
| ContentType | Journal Article |
| Copyright | 2017 Elsevier Ltd Copyright © 2017 Elsevier Ltd. All rights reserved. |
| Copyright_xml | – notice: 2017 Elsevier Ltd – notice: Copyright © 2017 Elsevier Ltd. All rights reserved. |
| DBID | AAYXX CITATION NPM 7X8 |
| DOI | 10.1016/j.phrs.2017.09.020 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1096-1186 |
| EndPage | 25 |
| ExternalDocumentID | 28964914 10_1016_j_phrs_2017_09_020 S1043661817307995 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- --K --M .GJ .~1 0R~ 0SF 0ZK 123 1B1 1RT 1~. 1~5 29O 3O- 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATCM AAXUO ABFNM ABFRF ABJNI ABMAC ABOCM ABXDB ABYKQ ABZDS ACDAQ ACGFO ACGFS ACRLP ADBBV ADEZE ADFGL ADMUD AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC C45 CAG COF CS3 DM4 DU5 EBS EFBJH EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA GROUPED_DOAJ HMT HVGLF HX~ HZ~ IHE J1W KOM L7B LG5 M33 M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SCC SDF SDG SDP SES SEW SPCBC SPT SSP SSZ T5K TEORI UNMZH WUQ XPP ZA5 ZU3 ZXP ~G- AATTM AAXKI AAYWO AAYXX ABWVN ACRPL ACVFH ADCNI ADNMO ADVLN AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP BNPGV CITATION SSH EFKBS NPM 7X8 ACLOT ~HD |
| ID | FETCH-LOGICAL-c422t-303928be653e90a180ce8a9838409bfcadd672862008646b998b72e4cc4518a03 |
| IEDL.DBID | AIKHN |
| ISSN | 1043-6618 1096-1186 |
| IngestDate | Sat Sep 27 18:04:33 EDT 2025 Mon Jul 21 05:55:54 EDT 2025 Thu Apr 24 22:50:43 EDT 2025 Tue Jul 01 03:33:40 EDT 2025 Fri Feb 23 02:19:14 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Cardiotoxicity Cardiac progenitor cells Imatinib mesylate Kit |
| Language | English |
| License | Copyright © 2017 Elsevier Ltd. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c422t-303928be653e90a180ce8a9838409bfcadd672862008646b998b72e4cc4518a03 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 28964914 |
| PQID | 1945717614 |
| PQPubID | 23479 |
| PageCount | 11 |
| ParticipantIDs | proquest_miscellaneous_1945717614 pubmed_primary_28964914 crossref_citationtrail_10_1016_j_phrs_2017_09_020 crossref_primary_10_1016_j_phrs_2017_09_020 elsevier_sciencedirect_doi_10_1016_j_phrs_2017_09_020 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | January 2018 2018-01-00 20180101 |
| PublicationDateYYYYMMDD | 2018-01-01 |
| PublicationDate_xml | – month: 01 year: 2018 text: January 2018 |
| PublicationDecade | 2010 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Pharmacological research |
| PublicationTitleAlternate | Pharmacol Res |
| PublicationYear | 2018 |
| Publisher | Elsevier Ltd |
| Publisher_xml | – name: Elsevier Ltd |
| References | Force, Krause, Van Etten (bib0160) 2007; 7 Quesenberry, Colvin, Lambert (bib0220) 2002; 100 Force, Kolaja (bib0015) 2011; 10 Piegari, Russo, Cappetta, Esposito, Urbanek, Dell’Aversana (bib0125) 2016; 7 Yanamandala, Zhu, Garry, Kamp, Hare, Jun (bib0095) 2017; 70 Di Meglio, Nurzynska, Castaldo, Miraglia, Romano, De Angelis (bib0140) 2012; 16 Cimini, Fazel, Zhuo, Xaymardan, Fujii, Weisel, Li (bib0200) 2007; 116 De Angelis, Piegari, Cappetta, Russo, Esposito, Ciuffreda (bib0120) 2015; 189 D’Amario, Leone, Narducci, Smaldone, Lecis, Inzani (bib0100) 2017; 241 Suter, Procter, van Veldhuisen, Muscholl, Bergh, Carlomagno (bib0020) 2007; 25 Gude, Sussman (bib0065) 2018; 127 Kerkelä, Grazette, Yacobi, Iliescu, Patten, Beahm (bib0050) 2006; 12 Apperley, Gardembas, Melo, Russell-Jones, Bain, Baxter (bib0025) 2002; 347 Ishikawa, Fish, Aguero, Yaniz-Galende, Jeong, Kho (bib0195) 2015; 8 Harivenkatesh, Kumar, Bakhshi, Sharma, Kabra, Velpandian (bib0035) 2017; 120 Beltrami AP, Madeddu P (bib0060) 2018; 127 Nadal-Ginard, Ellison, Torella (bib0075) 2014; 13 Geng, Ye, Yeghiazarians, Shih, Hwang, Sievers (bib0185) 2017; 7 Lengline, Beldjord, Dombret, Soulier, Boissel, Clappier (bib0045) 2013; 98 Groarke, Cheng, Moslehi (bib0055) 2013; 369 Makkar, Smith, Cheng, Malliaras, Thomson, Berman (bib0175) 2012; 379 Vajravelu, Hong, Al-Maqtari, Cao, Keith, Wysoczynski (bib0135) 2015; 10 McQualter, Yuen, Williams, Bertoncello (bib0215) 2010; 107 Cappetta, Rossi, Piegari, Quaini, Berrino, Urbanek, De Angelis (bib0155) 2018; 127 Hatzistergos, Saur, Seidler, Balkan, Breton, Valasaki (bib0180) 2016; 119 Bolli, Chugh, D’Amario, Loughran, Stoddard, Ikram (bib0170) 2011; 378 Sanz-Ruiz, Fernández-Avilés (bib0080) 2018; 127 Yaniz-Galende, Chen, Chemaly, Liang, Hulot, McCollum (bib0190) 2012; 111 De Angelis, Piegari, Cappetta, Marino, Filippelli, Berrino (bib0105) 2010; 121 Tokita, Maki, Tadokoro, Nakamura, Arai, Sasaki (bib0040) 2007; 21 Piegari, De Angelis, Cappetta, Russo, Esposito, Costantino (bib0115) 2013; 108 Leri, Rota, Pasqualini, Goichberg, Anversa (bib0070) 2015; 116 De Angelis, Urbanek, Cappetta, Piegari, Ciuffreda, Rivellino (bib0150) 2016; 2 Chen, Frangogiannis (bib0205) 2013; 1833 Oeffinger, Mertens, Sklar, Kawashima, Hudson, Meadows (bib0005) 2006; 355 Chong, Reinecke, Iwata, Torok-Storb, Stempien-Otero, Murry (bib0225) 2013; 22 Charaf, Mahon, Lamrissi-Garcia, Moranvillier, Beliveau, Cardinaud (bib0210) 2017; 31 Savi, Bocchi, Rossi, Frati, Graiani, Lagrasta (bib0145) 2016; 310 Smith, Lewis, Aquila, Waring, Nocera, Agosti (bib0165) 2014; 9 Jovenaux, Cautela, Resseguier, Pibarot, Taouqi, Orabona (bib0010) 2017; 241 Leong, Ng, Ellison-Hughes, Tan (bib0090) 2017; 4 Prezioso, Tanzi, Galaverna, Frati, Testa, Savi (bib0130) 2010; 8 Kurtovic-Kozaric, Kugic, Hasic, Beslija, Ceric, Pasic (bib0030) 2017; 78 Nigro, Bassetti, Cavallotti, Catto, Carbucicchio, Pompilio (bib0085) 2018; 127 Huang, Zhang, Ramil, Rikka, Kim, Lee (bib0110) 2010; 121 Force (10.1016/j.phrs.2017.09.020_bib0015) 2011; 10 Groarke (10.1016/j.phrs.2017.09.020_bib0055) 2013; 369 Quesenberry (10.1016/j.phrs.2017.09.020_bib0220) 2002; 100 Piegari (10.1016/j.phrs.2017.09.020_bib0115) 2013; 108 Cappetta (10.1016/j.phrs.2017.09.020_bib0155) 2018; 127 Smith (10.1016/j.phrs.2017.09.020_bib0165) 2014; 9 De Angelis (10.1016/j.phrs.2017.09.020_bib0105) 2010; 121 Force (10.1016/j.phrs.2017.09.020_bib0160) 2007; 7 Di Meglio (10.1016/j.phrs.2017.09.020_bib0140) 2012; 16 Savi (10.1016/j.phrs.2017.09.020_bib0145) 2016; 310 Suter (10.1016/j.phrs.2017.09.020_bib0020) 2007; 25 Hatzistergos (10.1016/j.phrs.2017.09.020_bib0180) 2016; 119 Bolli (10.1016/j.phrs.2017.09.020_bib0170) 2011; 378 Apperley (10.1016/j.phrs.2017.09.020_bib0025) 2002; 347 Nadal-Ginard (10.1016/j.phrs.2017.09.020_bib0075) 2014; 13 Makkar (10.1016/j.phrs.2017.09.020_bib0175) 2012; 379 Sanz-Ruiz (10.1016/j.phrs.2017.09.020_bib0080) 2018; 127 Geng (10.1016/j.phrs.2017.09.020_bib0185) 2017; 7 Kurtovic-Kozaric (10.1016/j.phrs.2017.09.020_bib0030) 2017; 78 D’Amario (10.1016/j.phrs.2017.09.020_bib0100) 2017; 241 Jovenaux (10.1016/j.phrs.2017.09.020_bib0010) 2017; 241 Lengline (10.1016/j.phrs.2017.09.020_bib0045) 2013; 98 Ishikawa (10.1016/j.phrs.2017.09.020_bib0195) 2015; 8 Leri (10.1016/j.phrs.2017.09.020_bib0070) 2015; 116 Piegari (10.1016/j.phrs.2017.09.020_bib0125) 2016; 7 Prezioso (10.1016/j.phrs.2017.09.020_bib0130) 2010; 8 Gude (10.1016/j.phrs.2017.09.020_bib0065) 2018; 127 Beltrami AP (10.1016/j.phrs.2017.09.020_bib0060) 2018; 127 De Angelis (10.1016/j.phrs.2017.09.020_bib0120) 2015; 189 Chen (10.1016/j.phrs.2017.09.020_bib0205) 2013; 1833 Oeffinger (10.1016/j.phrs.2017.09.020_bib0005) 2006; 355 Chong (10.1016/j.phrs.2017.09.020_bib0225) 2013; 22 Nigro (10.1016/j.phrs.2017.09.020_bib0085) 2018; 127 Harivenkatesh (10.1016/j.phrs.2017.09.020_bib0035) 2017; 120 Huang (10.1016/j.phrs.2017.09.020_bib0110) 2010; 121 Vajravelu (10.1016/j.phrs.2017.09.020_bib0135) 2015; 10 Charaf (10.1016/j.phrs.2017.09.020_bib0210) 2017; 31 McQualter (10.1016/j.phrs.2017.09.020_bib0215) 2010; 107 Yaniz-Galende (10.1016/j.phrs.2017.09.020_bib0190) 2012; 111 Cimini (10.1016/j.phrs.2017.09.020_bib0200) 2007; 116 Tokita (10.1016/j.phrs.2017.09.020_bib0040) 2007; 21 Leong (10.1016/j.phrs.2017.09.020_bib0090) 2017; 4 Kerkelä (10.1016/j.phrs.2017.09.020_bib0050) 2006; 12 De Angelis (10.1016/j.phrs.2017.09.020_bib0150) 2016; 2 Yanamandala (10.1016/j.phrs.2017.09.020_bib0095) 2017; 70 |
| References_xml | – volume: 379 start-page: 895 year: 2012 end-page: 904 ident: bib0175 article-title: Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): A prospective, randomised phase 1 trial publication-title: Lancet – volume: 121 start-page: 675 year: 2010 end-page: 683 ident: bib0110 article-title: Juvenile exposure to anthracyclines impairs cardiac progenitor cell function and vascularization resulting in greater susceptibility to stress-induced myocardial injury in adult mice publication-title: Circulation – volume: 31 start-page: 65 year: 2017 end-page: 74 ident: bib0210 article-title: Effect of tyrosine kinase inhibitors on stemness in normal and chronic myeloid leukemia cells publication-title: Leukemia – volume: 7 start-page: 332 year: 2007 end-page: 344 ident: bib0160 article-title: Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition publication-title: Nat. Rev. Cancer – volume: 4 start-page: 47 year: 2017 ident: bib0090 article-title: Cardiac stem cells for myocardial regeneration: they are not alone publication-title: Front. Cardiovasc. Med. – volume: 7 start-page: 62312 year: 2016 end-page: 62326 ident: bib0125 article-title: MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat publication-title: Oncotarget – volume: 378 start-page: 1847 year: 2011 end-page: 1857 ident: bib0170 article-title: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): Initial results of a randomised phase 1 trial publication-title: Lancet – volume: 127 start-page: 101 year: 2018 end-page: 109 ident: bib0060 article-title: Pericytes and cardiac stem cells: common features and peculiarities publication-title: Pharmacol. Res. – volume: 22 start-page: 1932 year: 2013 end-page: 1943 ident: bib0225 article-title: Progenitor cells identified by PDGFR-alpha expression in the developing and diseased human heart publication-title: Stem Cells Dev. – volume: 127 start-page: 92 year: 2018 end-page: 100 ident: bib0080 article-title: Autologous and allogeneic cardiac stem cell therapy for cardiovascular diseases publication-title: Pharmacol. Res. – volume: 25 start-page: 3859 year: 2007 end-page: 3865 ident: bib0020 article-title: Trastuzumab associated cardiac adverse effects in the Herceptin adjuvant trial publication-title: J. Clin. Oncol. – volume: 21 start-page: 190 year: 2007 end-page: 192 ident: bib0040 article-title: Chronic idiopathic myelofibrosis expressing a novel type of TEL-PDGFRB chimaera responded to imatinib mesylate therapy publication-title: Leukemia – volume: 347 start-page: 481 year: 2002 end-page: 487 ident: bib0025 article-title: Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta publication-title: N. Engl. J. Med. – volume: 78 start-page: 118 year: 2017 end-page: 121 ident: bib0030 article-title: Long-term outcome of GIST patients treated with delayed imatinib therapy publication-title: Eur. J. Cancer – volume: 241 start-page: 330 year: 2017 end-page: 343 ident: bib0100 article-title: Human cardiac progenitor cells with regenerative potential can be isolated and characterized from 3D-electro-anatomic guided endomyocardial biopsies publication-title: Int. J. Cardiol. – volume: 107 start-page: 1414 year: 2010 end-page: 1419 ident: bib0215 article-title: Evidence of an epithelial stem/progenitor cell hierarchy in the adult mouse lung publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 127 start-page: 110 year: 2018 end-page: 115 ident: bib0065 article-title: Chasing c-kit through the heart: taking a broader view publication-title: Pharmacol. Res. – volume: 13 start-page: 615 year: 2014 end-page: 630 ident: bib0075 article-title: The cardiac stem cell compartment is indispensable for myocardial cell homeostasis, repair and regeneration in the adult publication-title: Stem Cell Res. – volume: 189 start-page: 30 year: 2015 end-page: 44 ident: bib0120 article-title: SIRT1 activation rescues doxorubicin-induced loss of functional competence of human cardiac progenitor cells publication-title: Int. J. Cardiol. – volume: 10 start-page: 111 year: 2011 end-page: 126 ident: bib0015 article-title: Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes publication-title: Nat. Rev. Drug Discov. – volume: 98 start-page: e146 year: 2013 end-page: e148 ident: bib0045 article-title: Successful tyrosine kinase therapy in a refractory B-cell precursor acute lymphoblastic leukemia with EBF1-PDGFRB fusion publication-title: Haematologica – volume: 127 start-page: 77 year: 2018 end-page: 91 ident: bib0085 article-title: Cell therapy for heart disease after 15 years: unmet expectations publication-title: Pharmacol. Res. – volume: 12 start-page: 908 year: 2006 end-page: 916 ident: bib0050 article-title: Cardiotoxicity of the cancer therapeutic agent imatinib mesylate publication-title: Nat. Med. – volume: 116 start-page: I77 year: 2007 end-page: I82 ident: bib0200 article-title: c-kit dysfunction impairs myocardial healing after infarction publication-title: Circulation – volume: 8 start-page: 55 year: 2010 end-page: 75 ident: bib0130 article-title: Cancer treatment-induced cardiotoxicity: a cardiac stem cell disease? publication-title: Cardiovasc. Hematol. Agents Med. Chem. – volume: 116 start-page: 150 year: 2015 end-page: 166 ident: bib0070 article-title: Origin of cardiomyocytes in the adult heart publication-title: Circ. Res. – volume: 8 start-page: 167 year: 2015 end-page: 174 ident: bib0195 article-title: Stem cell factor gene transfer improves cardiac function after myocardial infarction in swine publication-title: Circ. Heart Fail. – volume: 119 start-page: 921 year: 2016 end-page: 930 ident: bib0180 article-title: Stimulatory effects of mesenchymal stem cells on cKit+ cardiac stem cells are mediated by SDF1/CXCR4 and SCF/cKit signaling pathway publication-title: Circ. Res. – volume: 111 start-page: 1434 year: 2012 end-page: 1445 ident: bib0190 article-title: Stem cell factor gene transfer promotes cardiac repair after myocardial infarction via in situ recruitment and expansion of c-kit+ cells publication-title: Circ. Res. – volume: 127 start-page: 4 year: 2018 end-page: 14 ident: bib0155 article-title: Doxorubicin targets multiple players: a new view of an old problem publication-title: Pharmacol. Res. – volume: 121 start-page: 276 year: 2010 end-page: 292 ident: bib0105 article-title: Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function publication-title: Circulation – volume: 369 start-page: 1779 year: 2013 end-page: 1781 ident: bib0055 article-title: Cancer-drug discovery and cardiovascular surveillance publication-title: N. Engl. J. Med. – volume: 10 start-page: e0140798 year: 2015 ident: bib0135 article-title: c-Kit promotes growth and migration of human cardiac progenitor cells via the PI3K-AKT and MEK-ERK pathways publication-title: PLoS One – volume: 355 start-page: 1572 year: 2006 end-page: 1582 ident: bib0005 article-title: Chronic health conditions in adult survivors of childhood cancer publication-title: N. Engl. J. Med. – volume: 70 start-page: 766 year: 2017 end-page: 775 ident: bib0095 article-title: Overcoming the roadblocks to cardiac cell therapy using tissue engineering publication-title: J. Am. Coll. Cardiol. – volume: 120 start-page: 138 year: 2017 end-page: 145 ident: bib0035 article-title: Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in newly diagnosed patients with chronic myeloid leukemia publication-title: Pharmacol. Res. – volume: 241 start-page: 387 year: 2017 end-page: 392 ident: bib0010 article-title: Practices in management of cancer treatment-related cardiovascular toxicity: a cardio-oncology survey publication-title: Int. J. Cardiol. – volume: 9 start-page: 1662 year: 2014 end-page: 1681 ident: bib0165 article-title: Isolation and characterization of resident endogenous c-Kit+ cardiac stem cells from the adult mouse and rat heart publication-title: Nat. Protoc. – volume: 1833 start-page: 945 year: 2013 end-page: 953 ident: bib0205 article-title: Fibroblasts in post-infarction inflammation and cardiac repair publication-title: Biochim. Biophys. Acta – volume: 310 start-page: H1622 year: 2016 end-page: H1648 ident: bib0145 article-title: Antiarrhythmic effect of growth factor-supplemented cardiac progenitor cells in chronic infarcted heart publication-title: Am. J. Physiol. Heart Circ. Physiol. – volume: 2 start-page: 2 year: 2016 ident: bib0150 article-title: Doxorubicin cardiotoxicity and target cells: a broader perspective publication-title: Cardio-Oncology – volume: 7 start-page: 77 year: 2017 end-page: 82 ident: bib0185 article-title: Myocardial production and release of stem cell factor following myocardial infarctio publication-title: J. Biomater. Tissue Eng. – volume: 108 start-page: 334 year: 2013 ident: bib0115 article-title: Doxorubicin induces senescence and impairs function of human cardiac progenitor cells publication-title: Basic Res. Cardiol. – volume: 16 start-page: 936 year: 2012 end-page: 942 ident: bib0140 article-title: Cardiac shock wave therapy: assessment of safety and new insights into mechanisms of tissue regeneration publication-title: J. Cell. Mol. Med. – volume: 100 start-page: 4266 year: 2002 end-page: 4271 ident: bib0220 article-title: The chiaroscuro stem cell: a unified stem cell theory publication-title: Blood – volume: 127 start-page: 110 year: 2018 ident: 10.1016/j.phrs.2017.09.020_bib0065 article-title: Chasing c-kit through the heart: taking a broader view publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2017.06.007 – volume: 108 start-page: 334 year: 2013 ident: 10.1016/j.phrs.2017.09.020_bib0115 article-title: Doxorubicin induces senescence and impairs function of human cardiac progenitor cells publication-title: Basic Res. Cardiol. doi: 10.1007/s00395-013-0334-4 – volume: 78 start-page: 118 year: 2017 ident: 10.1016/j.phrs.2017.09.020_bib0030 article-title: Long-term outcome of GIST patients treated with delayed imatinib therapy publication-title: Eur. J. Cancer doi: 10.1016/j.ejca.2017.03.024 – volume: 98 start-page: e146 year: 2013 ident: 10.1016/j.phrs.2017.09.020_bib0045 article-title: Successful tyrosine kinase therapy in a refractory B-cell precursor acute lymphoblastic leukemia with EBF1-PDGFRB fusion publication-title: Haematologica doi: 10.3324/haematol.2013.095372 – volume: 116 start-page: 150 year: 2015 ident: 10.1016/j.phrs.2017.09.020_bib0070 article-title: Origin of cardiomyocytes in the adult heart publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.116.303595 – volume: 9 start-page: 1662 year: 2014 ident: 10.1016/j.phrs.2017.09.020_bib0165 article-title: Isolation and characterization of resident endogenous c-Kit+ cardiac stem cells from the adult mouse and rat heart publication-title: Nat. Protoc. doi: 10.1038/nprot.2014.113 – volume: 7 start-page: 77 year: 2017 ident: 10.1016/j.phrs.2017.09.020_bib0185 article-title: Myocardial production and release of stem cell factor following myocardial infarctio publication-title: J. Biomater. Tissue Eng. doi: 10.1166/jbt.2017.1543 – volume: 31 start-page: 65 year: 2017 ident: 10.1016/j.phrs.2017.09.020_bib0210 article-title: Effect of tyrosine kinase inhibitors on stemness in normal and chronic myeloid leukemia cells publication-title: Leukemia doi: 10.1038/leu.2016.154 – volume: 241 start-page: 387 year: 2017 ident: 10.1016/j.phrs.2017.09.020_bib0010 article-title: Practices in management of cancer treatment-related cardiovascular toxicity: a cardio-oncology survey publication-title: Int. J. Cardiol. doi: 10.1016/j.ijcard.2017.02.154 – volume: 10 start-page: 111 year: 2011 ident: 10.1016/j.phrs.2017.09.020_bib0015 article-title: Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd3252 – volume: 25 start-page: 3859 year: 2007 ident: 10.1016/j.phrs.2017.09.020_bib0020 article-title: Trastuzumab associated cardiac adverse effects in the Herceptin adjuvant trial publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2006.09.1611 – volume: 7 start-page: 62312 year: 2016 ident: 10.1016/j.phrs.2017.09.020_bib0125 article-title: MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat publication-title: Oncotarget doi: 10.18632/oncotarget.11468 – volume: 379 start-page: 895 year: 2012 ident: 10.1016/j.phrs.2017.09.020_bib0175 article-title: Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): A prospective, randomised phase 1 trial publication-title: Lancet doi: 10.1016/S0140-6736(12)60195-0 – volume: 12 start-page: 908 year: 2006 ident: 10.1016/j.phrs.2017.09.020_bib0050 article-title: Cardiotoxicity of the cancer therapeutic agent imatinib mesylate publication-title: Nat. Med. doi: 10.1038/nm1446 – volume: 111 start-page: 1434 year: 2012 ident: 10.1016/j.phrs.2017.09.020_bib0190 article-title: Stem cell factor gene transfer promotes cardiac repair after myocardial infarction via in situ recruitment and expansion of c-kit+ cells publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.111.263830 – volume: 8 start-page: 167 year: 2015 ident: 10.1016/j.phrs.2017.09.020_bib0195 article-title: Stem cell factor gene transfer improves cardiac function after myocardial infarction in swine publication-title: Circ. Heart Fail. doi: 10.1161/CIRCHEARTFAILURE.114.001711 – volume: 241 start-page: 330 year: 2017 ident: 10.1016/j.phrs.2017.09.020_bib0100 article-title: Human cardiac progenitor cells with regenerative potential can be isolated and characterized from 3D-electro-anatomic guided endomyocardial biopsies publication-title: Int. J. Cardiol. doi: 10.1016/j.ijcard.2017.02.106 – volume: 4 start-page: 47 year: 2017 ident: 10.1016/j.phrs.2017.09.020_bib0090 article-title: Cardiac stem cells for myocardial regeneration: they are not alone publication-title: Front. Cardiovasc. Med. doi: 10.3389/fcvm.2017.00047 – volume: 1833 start-page: 945 year: 2013 ident: 10.1016/j.phrs.2017.09.020_bib0205 article-title: Fibroblasts in post-infarction inflammation and cardiac repair publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbamcr.2012.08.023 – volume: 127 start-page: 4 year: 2018 ident: 10.1016/j.phrs.2017.09.020_bib0155 article-title: Doxorubicin targets multiple players: a new view of an old problem publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2017.03.016 – volume: 107 start-page: 1414 year: 2010 ident: 10.1016/j.phrs.2017.09.020_bib0215 article-title: Evidence of an epithelial stem/progenitor cell hierarchy in the adult mouse lung publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0909207107 – volume: 13 start-page: 615 year: 2014 ident: 10.1016/j.phrs.2017.09.020_bib0075 article-title: The cardiac stem cell compartment is indispensable for myocardial cell homeostasis, repair and regeneration in the adult publication-title: Stem Cell Res. doi: 10.1016/j.scr.2014.04.008 – volume: 8 start-page: 55 year: 2010 ident: 10.1016/j.phrs.2017.09.020_bib0130 article-title: Cancer treatment-induced cardiotoxicity: a cardiac stem cell disease? publication-title: Cardiovasc. Hematol. Agents Med. Chem. doi: 10.2174/187152510790796165 – volume: 21 start-page: 190 year: 2007 ident: 10.1016/j.phrs.2017.09.020_bib0040 article-title: Chronic idiopathic myelofibrosis expressing a novel type of TEL-PDGFRB chimaera responded to imatinib mesylate therapy publication-title: Leukemia doi: 10.1038/sj.leu.2404397 – volume: 22 start-page: 1932 year: 2013 ident: 10.1016/j.phrs.2017.09.020_bib0225 article-title: Progenitor cells identified by PDGFR-alpha expression in the developing and diseased human heart publication-title: Stem Cells Dev. doi: 10.1089/scd.2012.0542 – volume: 121 start-page: 276 year: 2010 ident: 10.1016/j.phrs.2017.09.020_bib0105 article-title: Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.895771 – volume: 16 start-page: 936 year: 2012 ident: 10.1016/j.phrs.2017.09.020_bib0140 article-title: Cardiac shock wave therapy: assessment of safety and new insights into mechanisms of tissue regeneration publication-title: J. Cell. Mol. Med. doi: 10.1111/j.1582-4934.2011.01393.x – volume: 100 start-page: 4266 year: 2002 ident: 10.1016/j.phrs.2017.09.020_bib0220 article-title: The chiaroscuro stem cell: a unified stem cell theory publication-title: Blood doi: 10.1182/blood-2002-04-1246 – volume: 70 start-page: 766 year: 2017 ident: 10.1016/j.phrs.2017.09.020_bib0095 article-title: Overcoming the roadblocks to cardiac cell therapy using tissue engineering publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2017.06.012 – volume: 119 start-page: 921 year: 2016 ident: 10.1016/j.phrs.2017.09.020_bib0180 article-title: Stimulatory effects of mesenchymal stem cells on cKit+ cardiac stem cells are mediated by SDF1/CXCR4 and SCF/cKit signaling pathway publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.116.309281 – volume: 310 start-page: H1622 year: 2016 ident: 10.1016/j.phrs.2017.09.020_bib0145 article-title: Antiarrhythmic effect of growth factor-supplemented cardiac progenitor cells in chronic infarcted heart publication-title: Am. J. Physiol. Heart Circ. Physiol. doi: 10.1152/ajpheart.00035.2015 – volume: 120 start-page: 138 year: 2017 ident: 10.1016/j.phrs.2017.09.020_bib0035 article-title: Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in newly diagnosed patients with chronic myeloid leukemia publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2017.03.011 – volume: 2 start-page: 2 year: 2016 ident: 10.1016/j.phrs.2017.09.020_bib0150 article-title: Doxorubicin cardiotoxicity and target cells: a broader perspective publication-title: Cardio-Oncology doi: 10.1186/s40959-016-0012-4 – volume: 378 start-page: 1847 year: 2011 ident: 10.1016/j.phrs.2017.09.020_bib0170 article-title: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): Initial results of a randomised phase 1 trial publication-title: Lancet doi: 10.1016/S0140-6736(11)61590-0 – volume: 116 start-page: I77 year: 2007 ident: 10.1016/j.phrs.2017.09.020_bib0200 article-title: c-kit dysfunction impairs myocardial healing after infarction publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.107.708107 – volume: 7 start-page: 332 year: 2007 ident: 10.1016/j.phrs.2017.09.020_bib0160 article-title: Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2106 – volume: 10 start-page: e0140798 year: 2015 ident: 10.1016/j.phrs.2017.09.020_bib0135 article-title: c-Kit promotes growth and migration of human cardiac progenitor cells via the PI3K-AKT and MEK-ERK pathways publication-title: PLoS One doi: 10.1371/journal.pone.0140798 – volume: 121 start-page: 675 year: 2010 ident: 10.1016/j.phrs.2017.09.020_bib0110 article-title: Juvenile exposure to anthracyclines impairs cardiac progenitor cell function and vascularization resulting in greater susceptibility to stress-induced myocardial injury in adult mice publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.902221 – volume: 189 start-page: 30 year: 2015 ident: 10.1016/j.phrs.2017.09.020_bib0120 article-title: SIRT1 activation rescues doxorubicin-induced loss of functional competence of human cardiac progenitor cells publication-title: Int. J. Cardiol. doi: 10.1016/j.ijcard.2015.03.438 – volume: 127 start-page: 101 year: 2018 ident: 10.1016/j.phrs.2017.09.020_bib0060 article-title: Pericytes and cardiac stem cells: common features and peculiarities publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2017.05.023 – volume: 369 start-page: 1779 year: 2013 ident: 10.1016/j.phrs.2017.09.020_bib0055 article-title: Cancer-drug discovery and cardiovascular surveillance publication-title: N. Engl. J. Med. doi: 10.1056/NEJMp1313140 – volume: 347 start-page: 481 year: 2002 ident: 10.1016/j.phrs.2017.09.020_bib0025 article-title: Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa020150 – volume: 127 start-page: 92 year: 2018 ident: 10.1016/j.phrs.2017.09.020_bib0080 article-title: Autologous and allogeneic cardiac stem cell therapy for cardiovascular diseases publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2017.05.024 – volume: 355 start-page: 1572 year: 2006 ident: 10.1016/j.phrs.2017.09.020_bib0005 article-title: Chronic health conditions in adult survivors of childhood cancer publication-title: N. Engl. J. Med. doi: 10.1056/NEJMsa060185 – volume: 127 start-page: 77 year: 2018 ident: 10.1016/j.phrs.2017.09.020_bib0085 article-title: Cell therapy for heart disease after 15 years: unmet expectations publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2017.02.015 |
| SSID | ssj0009410 |
| Score | 2.30288 |
| Snippet | [Display omitted]
Cardiovascular complications are included among the systemic effects of tyrosine kinase inhibitor (TKI)-based therapeutic strategies. To test... Cardiovascular complications are included among the systemic effects of tyrosine kinase inhibitor (TKI)-based therapeutic strategies. To test the hypothesis... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 15 |
| SubjectTerms | Cardiac progenitor cells Cardiotoxicity Imatinib mesylate |
| Title | Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors |
| URI | https://dx.doi.org/10.1016/j.phrs.2017.09.020 https://www.ncbi.nlm.nih.gov/pubmed/28964914 https://www.proquest.com/docview/1945717614 |
| Volume | 127 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS-RAEC50vHgRdX2MutIL4kXjdCedTOc4iDLu4iCo4K1JPwIjmhEzI-Tib7dqkjgIux72mJAmnapKVX1J1VcARyZMnHd5HlgnwkAqbgIV5QhWhEML8ZzbnLqRr0fJ8F7-fogfluC87YWhssrG99c-fe6tmzO9Rpq9l_G4dyuIPT3BCIVGSrRmy7ASYrRXHVgZXP0Zjhbcu7IlJYgCWtD0ztRlXigyYu0W_TndKY39_nt8-lf-OY9Dl-uw1iSQbFDvcQOWfLEJxzc1A3V1yu4WDVXlKTtmNwtu6uoHjK4oQy3Ghj37snrCRDNAUI7qdczOK1OfqwkNKa7YuEDH9eZLhnicBo9O6wsyy6iky5MneC234P7y4u58GDQjFQIrw3AaYMBCCRmfxJFPeSYUt15lqYoI55ncordL-iGiHII6MjEIxkw_9NJaGQuV8WgbOsWk8LvAuONpbkKXZUkiUxdnsTM2TlXfKS-Mj7ogWkFq2_CN09iLJ90Wlj1qEr4m4WueahR-F04-17zUbBvfXh23-tFfbEZjOPh23a9WmRpfJvpDkhV-Miu1SGWM-BZTli7s1Fr-3AciU3xOIff-8677sIpHqv58cwCd6evM_8SEZmoOYfnsXRw2ZvsBO-z2Gg |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEB6FcCiXqpQ-Ai3dSogLWNm11876GCFQUiBCapC4rbwPS0HBQTgg-d8zE9tElQoHrrZXXs-MZ-azZ74BODBh4rzL88A6EQZScROoKEewIhxaiOfc5tSNfDlJRtfyz01804GTtheGyiob31_79JW3bo70G2n272ez_l9B7OkJRig0UqI124BNSUOtu7A5HJ-PJmvuXdmSEkQBLWh6Z-oyLxQZsXaLwYrulMZ-_z8-vZZ_ruLQ2Sf42CSQbFjvcRs6vvgMh1c1A3V1zKbrhqrymB2yqzU3dbUDkzFlqMXMsDtfVnNMNAME5ahex-yqMvWuWtCQ4orNCnRcT75kiMdp8OiyviCzjEq6PHmCh_ILXJ-dTk9GQTNSIbAyDJcBBqw0VMYnceRTngnFrVdZqiLCeSa36O2SQYgoh6COTAyCMTMIvbRWxkJlPPoK3WJR-O_AuONpbkKXZUkiUxdnsTM2TtXAKS-Mj3ogWkFq2_CN09iLuW4Ly241CV-T8DVPNQq_B0cva-5rto03r45b_eh_bEZjOHhz3e9WmRpfJvpDkhV-8VhqkcoY8S2mLD34Vmv5ZR-ITPE5hdx9511_wYfR9PJCX4wn53uwhWdU_SnnB3SXD4_-JyY3S7PfGO8zCTj4AA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Imatinib+mesylate-induced+cardiomyopathy+involves+resident+cardiac+progenitors&rft.jtitle=Pharmacological+research&rft.au=Savi%2C+Monia&rft.au=Frati%2C+Caterina&rft.au=Cavalli%2C+Stefano&rft.au=Graiani%2C+Gallia&rft.date=2018-01-01&rft.issn=1096-1186&rft.eissn=1096-1186&rft.volume=127&rft.spage=15&rft_id=info:doi/10.1016%2Fj.phrs.2017.09.020&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1043-6618&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1043-6618&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1043-6618&client=summon |